Comparison of mealtime pramlintide, insulin, or a combination of both, when added to basal insulin treatment in patients with type 2 diabetes

被引：0
|
作者：
Karounos, D. [1 ,2 ]
Pencek, R. [3 ]
Huang, W. [3 ]
Miller, S. [3 ]
Lutz, K. [3 ]
Porter, L. [3 ]
机构：
[1] Lexington VA Med Ctr, Lexington, VA USA
[2] Univ Kentucky, Coll Med, Lexington, KY USA
[3] Amylin Pharmaceut Inc, San Diego, CA USA
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：S358 / S358
页数：1
相关论文
共 50 条
  • [21] Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus
    Yoon, Kun-Ho
    Hardy, Elise
    Han, Jenny
    [J]. DIABETES & METABOLISM JOURNAL, 2017, 41 (01) : 69 - 74
  • [22] Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
    Juurinen, L.
    Tiikkainen, M.
    Saltevo, J.
    Nikkila, K.
    Lanki, H.
    Leppavuori, E.
    Kock, T.
    Teikari-Myyra, T.
    Kauppinen-Makelin, R.
    Kotronen, A.
    Yki-Jarvinen, H.
    [J]. DIABETIC MEDICINE, 2009, 26 (04) : 409 - 415
  • [23] Primary Care Perspectives: The Effective Use of Mealtime and Basal Insulin Regimens in Patients with Type 2 Diabetes
    Banwell, Brenda
    Giovannoni, Gavin
    Hawkes, Chris
    Lublin, Fred
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (04) : A1 - A3
  • [24] Prandial-basal insulin regimens to improve mealtime glycaemia in type 2 diabetes: comparison of two approaches in starting and intensifying insulin
    Ilag, L. L.
    Mao, X.
    [J]. DIABETOLOGIA, 2009, 52 : S379 - S380
  • [25] EFFECT OF INSULIN TREATMENT INTENSIFICATION WITH INSULIN GLULISINE ADDED TO INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS IN ROMANIA
    Guja, Cristian
    Ioacara, Sorin
    Catrinoiu, Doina
    Negrisanu, Gabriela
    Popa, Amorin
    [J]. INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE, 2015, : 230 - 239
  • [26] Patients with type 1 diabetes: Perceptions associated with pramlintide as an adjunctive treatment to insulin
    Marrero, D
    Kruger, D
    Burrell, T
    Gloster, M
    Crean, J
    Herrmann, K
    Kolterman, O
    [J]. DIABETES, 2004, 53 : A137 - A138
  • [27] Patients with Type I diabetes: perceptions associated with pramlintide as an adjunctive treatment to insulin
    Marrero, D
    Kruger, D
    Burrell, T
    Gloster, M
    Crean, J
    Herrmann, K
    Maggs, D
    Kolterman, O
    [J]. DIABETOLOGIA, 2004, 47 : A283 - A283
  • [28] Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
    Rodrigo Oliveira Moreira
    Roberta Cobas
    Raquel C. Lopes Assis Coelho
    [J]. Diabetology & Metabolic Syndrome, 10
  • [29] Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
    Moreira, Rodrigo Oliveira
    Cobas, Roberta
    Lopes Assis Coelho, Raquel C.
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [30] The role of basal insulin in the treatment of type 2 diabetes
    Antsiferov, M. B.
    Petraneva, E. V.
    [J]. DIABETES MELLITUS, 2006, 9 (04): : 19 - 22
12345